For citations:
Balykova L.A., Krasnopolskaya A.V., Vereshchagina V.S., Shirmankina M.V., Pigacheva O.Yu., Stradina A.A., Ledyaykina S.A. Experience with a Genetically Engineering Biological Agent in a Child with Hypereosinophilic Syndrome Following Coronavirus Infection: Literature Review and Case Report. Pediatric pharmacology. 2026;23(2):62–71. (In Russ.) https://doi.org/10.15690/pf.v23i2.3028
JATS XML
Email this article 